Actively Recruiting
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
Led by Vastra Gotaland Region · Updated on 2025-11-18
40
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Proliferative diabetic retinopathy (PDR) is the leading cause for blindness in working-age adults. The current gold standard treatment for PDR is panretinal photocoagulation (PRP). In current clinical practice, both single-session and multiple-session PRP approaches are widely accepted and utilized. The purpose of this study is to compare the safety and effectiveness of single-session and multiple-session PRP.
CONDITIONS
Official Title
Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years
- Patients with type 1 or type 2 Diabetes Mellitus with newly diagnosed Proliferative Diabetic Retinopathy (PDR)
- Visual acuity ≥ 0.1 Snellen
- Central retinal thickness (CRT) less than 300 micrometers measured by OCT without cysts in the neuroretina
- Clear media and adequately dilated pupil for panretinal photocoagulation (PRP)
You will not qualify if you...
- Intraocular surgery within the last 4 months or planned within the next 3 months
- Previous or current center-involved diabetic macular edema (Ci-DME)
- Previous PRP, intravitreal treatment (IVT), or macular laser treatment in the study eye
- Treatment with medications known to increase risk of macular edema
- Media opacity preventing adequate PRP
- General medical condition making office laser treatment very difficult or impossible
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ögonmottagning Mölndal/SU
Mölndal, Sweden, 43130
Actively Recruiting
Research Team
I
Imadeddin Abu Ishkheidem, M.D.
CONTACT
S
Sofia Töyrä Silfverswärd, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here